Additional file 3: of Safety and efficacy of tofacitinib for up to 9.5â years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

Autor: JĂźrgen Wollenhaupt, Eun-Bong Lee, Curtis, Jeffrey, Silverfield, Joel, Ketti Terry, Koshika Soma, Mojcik, Chris, DeMasi, Ryan, Strengholt, Sander, Kwok, Kenneth, Lazariciu, Irina, Lisy Wang, Cohen, Stanley
Rok vydání: 2019
DOI: 10.6084/m9.figshare.7961651.v1
Popis: Table S2. Patient baseline demographic and disease characteristics.
Databáze: OpenAIRE